[WKL-1]Contributions to the early detection of Alzheimer's disease using analytical and medical technologies
Koichi Tanaka(Mass Spectrometry Research Laboratory, Shimadzu Corporation, Japan)
第62回日本核医学会学術総会/第42回日本核医学技術学会総会学術大会
2022年9月9日〜9月11日国立京都国際会館
当該イベント内で検索します。
検索する
第62回日本核医学会学術総会/第42回日本核医学技術学会総会学術大会
2022年9月9日〜9月11日国立京都国際会館
当該イベント内で検索します。
検索する検索結果(785)
[WPL-1]Molecular Brain Imaigng of Dementia: Emerging Diseases, Therapies, and Role of Imaging
Satoshi Minoshima(Department of Radiology and Imaging Sciences at the University of Utah, USA)
[WSY1-1]PSMA-directed Molecular Imaging and Therapy in Germany
Rudolf Werner(University Hospital Würzburg, Wuerzburg, Germany)
[WSY1-2]Prostate PSMA Directed Theranostics and Patient Selection: Current US Perspective and Future Directions
Steve Cho(University of Wisconsin - Madison, Wisconsin, USA)
[WSY1-3]PET imaging and therapy targeting PSMA: current status and perspective in Japan
Tadashi Watabe(Osaka University Osaka, Japan)
[WSY2-1]Update on Flortaucipir PET Imaging
Michael J. Pontecorvo(Avid Radiopharmaceuticals, Eli Lilly, Philadelphia, USA)
[WSY2-2]A biological staging system for Alzheimer’s disease
Pedro Rosa-Neto、Joseph Therriault、Andrea Benedet(McGill University, Montreal, Canada)
[WSY2-3]PET imaging of reactive astrocytes with [18F]SMBT-1 in dementia
Nobuyuki Okamura(Tohoku Medical and Pharmaceutical University, Sendai, Japan)
[WSY2-4]Imaging hallmark neuropathologies of neurodegenerative dementias
Makoto Higuchi(National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan)
[REP-1]Pediatrics
Zvi Bar-Sever(Israeli Society of Nuclear Medicine, Israel)
[REP-2]Pediatrics
Laura Drubach(Boston Children's Hospital, Boston, USA)
[REP-3]Pediatrics
Mayuki Uchiyama(The Jikei University School of Medicine)
[REC-1]Cardiology
Miller Robert J H(Department of Cardiac Sciences, University of Calgary, Canada)
[REC-2]Cardiology
Yuka Otaki(Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan)
[WTSY1-1]Current status of education and license system and the role of tech in QA/QC
Dusty York(Chattanooga State Community College, Georgia, USA)
[WTSY1-2]Current status of education and license system and the role of tech in QA/QC
Andrea Santos(Hospital Cuf Descobertas, Portugal)
[WTSY1-3]Current status of education and license system and the role of tech in QA/QC
Yuka Matsuura(Institute for Medical Regulatory Science, Waseda University, Tokyo, Japan)
[WTSY2-1]Standardization efforts for SPECT/CT - Focus on radionuclide therapy
Pedro Fragoso Costa(Department of nuclear medicine, University hospital of Essen, Essen, Germany)
[WTSY2-2]Role of the Japanese Society of Nuclear Medicine Technology Standardization Guidelines for SPECT Imaging: From the Present to the Future
Norikazu Matsutomo(Kyorin University, Tokyo, Japan)
[NL-1]Challenges of Nuclear Cardiology from a young Korean nuclear physician’s perspectives
Sang-Geon Cho(Chonnam National University Hospital, Korea)
[NL-2]The multiple facets of leadership in nuclear medicine
Thomas Hope(Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, USA)
[NL-3]A diverse and united leadership for the future of Nuclear Medicine: my point of view from Europe
Valentina Garibotto(Geneva University Hospitals, Switzerland)
[AS-1]Treatment Response Criteria in the Era of Cancer Immunotherapy
Hossein Jadvar(University of Southern California, USA)
[WPL-2]NUCLEAR CARDIOLOGY: NUCLEAR MEDICINE AND THE WORLD’S BIGGEST KILLER
Ignasi Carrió(Department of Nuclear Medicine Hospital Sant Pau, Autonomous University of Barcelona, Barcelona, Spain)
[WPL-3]From Innovation to Implementation: Advancing Radiomolecular Precision Oncology for Theranostics of Personalized Cancer Care
Richard Baum(Curanosticum Wiesbaden-Frankfurt, Germany)
[WSY3-1]Non-perfusion application of myocardial perfusion SPECT in ischemic heart disease: dyssynchrony and flow quantitation
Hung Guang-Uei(Chang Bing Show Chwan Memorial Hospital, Taiwan)
[WSY3-2]Molecular Image-Piloted Strategies - Established in Oncology, Ready for Cardiology?
Rudolf Werner(University Hospital Würzburg, Department of Nuclear Medicine, Germany)
[WSY3-3]Clinical Value of Myocardial Blood Flow Reserve
Dennis Calnon(OhioHealth Heart And Vascular Physicians, Ohio, USA)
[WSY3-4]Current and Novel Multimodality Imaging Approach in Nuclear Cardiology
Kenji Fukushima(Fukushima Medical University, Japan)
[WSY4-1]The Potential of Artificial Intelligence in Nuclear Medicine Imaging and Therapy
Kuangyu Shi1,2(1.University of Bern, Bern, Switzerland、2.Technical University of Munich, Germany)
[WSY4-2]AI-Driven Image Generation and Correction Techniques for PET and SPECT
Youngho Seo(University Of California, San Francisco, USA)
[WSY4-3]How should nuclear medicine specialists collaborate with AI?
Kenji Hirata(Hokkaido University, Hokkaido, Japan)
[WFS-1]The progress of development of At-211 targeted alpha particle therapy at Fukushima Medical University and possibilities of combined therapy with external-beam radiation and immunotherapy
Shunichi Yamashita、Tohru Shiga、Koshin Washiyama、Kazuhiro Takahashi、Yoshiyuki Suzuki(Research Center, Fukushima medical university, Fukushima, Japan)
[WFS-2]Synthesis of At-211 MABG
Kazuhiro Takahashi(Advanced clinical Research Center, Fukushima medical university, Fukushima, Japan)
[WFS-3]Integrated Radiation Therapy including At-211 alpha Nuclear Medicine Therapy
Yoshiyuki Suzuki(Advanced clinical Research Center, Department of Radiation Oncology, Fukushima medical university, Fukushima, Japan)
[WFL-1]An Overview of Theranostics – Current and Future Directions
Elizabeth Bailey(Royal North Shore, Australia)
[REN-1]Nerology
Tanyaluck Thientunyakit(Division of Nuclear Medicine, Department of Radiology Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand)
[REN-4]Nerology
Etsuko Imabayashi(National Institute for Quantum Science and Technology (QST) Quantum Life and Medical Science Directorate, Tokyo, Japan)
[REN-3]Nerology
Wen-Sheng Huang(Department of Nuclear Medicine, Taipei Medical University Hospital, Taiwan)
[RET-1]Technology
Takashi Kamiya(Osaka University Hospital, Osaka, Japan)
[RET-2]Technology
Kitiwat Khamwan(Chulalongkorn University, Thailand)
[AS-5]Translational medicine with the PET tracer for glutamate AMPA receptor
Takuya Takahashi(Yokohama City University, Graduate School Of Medicine, Yokohama, Japan)
[AS3-1]F-18 fluoro-borono-phenylalanine (FBPA) PET/CT to differentiate between malignant tumors and inflammation
Jun Hatazawa(Osaka University, Osaka, Japan)
[AS3-2]The incremental role of hybrid imaging in the diagnosis of infection/inflammation and neoplasia of the genito-urinary system
Ishita Sen(Fortis Memorial Research Institute, Gurugram, Haryana, India)
[AS3-4]Differentiation of Pulmonary Infection/Inflammation from Malignancy on Hybrid PET-CT Imaging
Punit Sharma(Nuclear Medicine,Apollo Hospital, Kolkata, India)
[AS3-5]Dynamics of hybrid imaging in differentiating malignancy from infection/ inflammation
Shrikant Solav(Spectlab, Pune, India)
[AS-4]Phronesis and Philosophy of Theranostic Cancer Care
J Harvey Turner(The University of Western Australia, Australia)
[WTSY3-1]Standardisation Efforts for PET/CT
Kunthi Pathmaraj1,2(1.Austin Health, Heidelberg, Australia、2.Olivia Newton John Cancer Research Institute)
[WTSY3-2]Japanese activities for standardization of quantitative PET imaging
Go Akamatsu1、Naoki Shimada2、Keiichi Matsumoto3、Hiromitsu Daisaki4、Kazufumi Suzuki5(1.National Institutes for Quantum Science and Technology (QST), Chiba, Japan、2.Cancer Institute Hospital, Tokyo, Japan、3.Kyoto College of Medical Science, Kyoto, Japan、4.Gunma Prefectural College of Health Sciences, Gunma, Japan、5.Dokkyo Medical University Hospital, Tokyo, Japan)
[WHO-1-1]WHO mandate and global partnership
Emilie VAN DEVENTER(World Heath Organization)
785 件中 ( 1 - 50 )
- 1
- ...